SCHEDULE 13G/A 0002050492 XXXXXXXX LIVE 2 Common Stock, par value $0.01 per share 09/30/2025 0001601485 Elicio Therapeutics, Inc. 28657F103 451 D STREET, 5TH FLOOR BOSTON MA 02210 Rule 13d-1(c) Actyus Private Equity SGIIC, S.A. U3 268564.00 0.00 268564.00 0.00 268564.00 1.6 IV FI Elicio Therapeutics, Inc. 451 D STREET, 5TH FLOOR, BOSTON, MASSACHUSETTS, 02210 Actyus Private Equity SGIIC, S.A., a Sociedad Anonima organized under the laws of Spain (Actyus or the Reporting Person), with respect to the shares of Common Stock (as defined in Item 2(d) below) held by NAVIS VB FUND I, a Fund organized under the laws of Spain (Navis). Actyus is the management company of the entity and acts on behalf of Navis investors' interests. Calle Serrano, 37 Madrid 28001 SPAIN SPAIN Y The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 16,338,284 shares of Common Stock outstanding as of August 5, 2025, as reported in the Company's Registration Statement on Form 10Q filed with the Securities and Exchange Commission on August 7, 2025. 1.64% 268,564 0 268,564 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Actyus Private Equity SGIIC, S.A. Yasmina Armengol Hierro 10/07/2025 Alessia Carretie Colombo 10/07/2025